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1. Introduction
In the early 1980’s our group was working on the synthesis of
monoterpene indole alkaloids and their derivatives. We were
particularly interested in four families: Corynanthe, Vinca-
Eburnane, Strychnos and Aspidosperma (Figure 1). Some
representatives of these families still find clinical use; vin-
camine, is used as a brain vasodilator in geriatric patients,
and vincristine is used as an antineoplasic agent in the treat-
ment of certain cancers. The widespread use of these drugs
is only possible, however, because chemical synthesis pro-
vides them in quantities not obtainable from natural sources,
where the amounts of the active principles are too low. In ad-
dition, these drugs are highly toxic. Less toxic and more
specific synthetic analogues could lead to the improvement
of the quality of life of patients under treatment. 
The four families of indole alkaloids mentioned above
were attractive as targets for synthesis because they share a
common structural feature, a 2-indolylpiperidine unit. Our
general synthetic approach was to focus on this moiety, us-
ing functionalized piperidine synthons as scaffolds to build
more complex molecules. The first piperidine synthon we
prepared was a 2-aryl-4-piperidone, reviewed in Section 2.
We have subsequently developed a number of piperidones
and applied them to the preparation of piperidine com-
pounds with biological interest. 
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Our early work on the synthesis of alkaloids that contain a
piperidine ring led us to prepare diversely functionalised
piperidines as scaffolds for building more complex struc-
tures. Since then we have prepared a number of piperidone
synthons, and we have applied these to the preparation of
biologically interesting compounds which range from alka-
loids to conformationally constrained pseudopeptides. We
provide here a brief historical introduction, followed by eight
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Resum
Els nostres treballs inicials sobre la síntesi d’alcaloides que
contenen un anell de piperidina en llur estructura, ens va
portar a la preparació de sintons piperidínics diversament
funcionalitzats sobre els quals construir molècules més
complexes. Des de llavors hem sintetitzat algunes piperi-
dones, que hem emprat per a la obtenció de compostos
amb interès biològic. Al llarg dels anys, aquests compostos
van des dels alcaloides fins a pseudopèptids de conforma-
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troducció històrica, seguida de vuit capítols corresponents
als sintons piperidínics més rellevants que hem desenvolu-
pat: i) 2-aril-4-piperidones, ii) 3-piperidein-2-ones i 2-ciano-
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At about this time, models to explain how biological recep-
tors operate were beginning to appear [1], although the rela-
tionship between structure and biological activity remained
largely mysterious. Thus, compounds of similar structure
proved to have different biological properties, and com-
pounds with very different structures were found to be useful
against the same disease. The possibility
of using rational design to improve mole-
cules showing potential clinical efficacy
was, consequently, very tempting. In-
deed, progress in understanding the
modes of action of compounds has since
aided the rational design of new «drug
leaders». Many compounds act by mim-
icking the action of endogenous pep-
tides, and peptide mimetics has become
an intensely active field of pharmacologi-
cal study. As our research has advanced,
we have continued to seek structures that
contain the piperidine core and that have
potential use in the pharmacological field.
By modifying our piperidine synthons we
have widened their scope, and our research has
evolved towards molecules that might act as small
peptidomimetics. The focus of our most recent work
is the preparation of 3-aminopiperidin-2-ones (Fig-
ure 2) whose backbone makes them intrinsically bio-
logically interesting (see for example, Section 4.1).
In addition, they can be considered as conforma-
tionally constrained dipeptide surrogates (see sec-
tion 5), and can be used to improve the activity of
known peptides. 
This review is organized into eight sections, each
devoted to one of the most relevant synthons on
which we have focused our work: 2-aryl-4-piperi-
dones (I), unsaturated valerolactams and 2-cya-
nopiperideines (II), 3-amino-2-arylpiperidin-4-ones
(III), 3-aminopiperidin-2-ones (IV), glutarimides (V),
enamides (VI), oxazolopiperidinones (VII), and hy-
droxylactams (VIII).
2. 2-Aryl-4-piperidones (I)
We developed our first synthon, 2-aryl-4-piperidone
I (Figure 2), with the aim of forging a new route to
the benzoquinolizidine alkaloids. At the time, the
known methods for obtaining this tricyclic structure
were closure of ring C by either Dieckmann cycliza-
tion or the Mannich reaction, and formation of the 11a-11b
bond through a Bishler-Napieralsky reaction (Figure 3). Our
approach was to close ring B by formation of the 7-7a bond
[2], for which we had first to prepare the appropriate 2-
phenyl-4-piperidone, a system that had never been de-
scribed.
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The synthesis of the required 2-phenylpiperidin-4-one was
achieved by condensation of the suitable primary aminoac-
etal with benzaldehyde, followed by an acid-promoted Man-
nich-type cyclisation (Figure 4) [3]. Indeed, in a dry acid
medium the protonation of the acetal allows the formation of
an enol ether which attacks the intramolecular iminium salt.
This proved to be a general method for obtaining protected 2-
aryl-4-piperidones 1, by using any aromatic aldehyde.
2.1. Corynanthe alkaloids
Our interest in the quinolizidines led us to attempt the prepa-
ration of Corynanthe indole alkaloids. The reported methods
for synthesis of the indolo[2,3-]quinolizidine ring system
were based on closure either of ring C through formation of
the C12a-C12b bond, or of ring D (Figure 5). We planned to ex-
plore the possibility of applying our method to close ring C
by formation of the C7-C7a bond.
We discovered that the treatment with KtBuO of a 2-(2-in-
dolyl)piperidine 2, whose indole nucleus was protected with
a phenylsulfonyl group and whose piperidine nitrogen atom
carried 2-hydroxyethyl chain, yielded directly the indolo-
quinolizidine system 3 (Figure 6). However, pyridopyrazi-
noindole 4 was also obtained. This result, together with
Figure 5
Figure 6
Figure 7
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those of other experiments, allowed us to give a mechanistic
explanation [4].
The KtBuO acted as a nucleophile on the sulfonyl group,
allowing its migration to the alcoholate via transesterification.
The resulting intermediate 5 underwent intramolecular at-
tack of the bidentated indole anion on the sulfoxyl leaving
group. Thus, the indoloquinolizidine system was obtained in
one step as a product of cyclisation on the indole 3-position,
although inevitably accompanied by the pyridopyrazinoin-
dole that results from cyclisation on the indole nitrogen atom.
To avoid the formation of the undesired regioisomer, we
applied the reaction to a 2-(3-indolyl)piperidine 6. In this
case, the intermediate formed with KtBuO would be a spiroin-
dolenine 7, which was known to rearrange to the desired
quinolizidine upon treatment with a Lewis acid (Figure 7) [5].
Structurally, the intermediate spiroindolenines 7 consti-
tute the ABCD ring system characteristic of Aspidosperma
and Strychnos alkaloids, so we considered the possibility of
building the fifth E ring by integrating a carbonated chain
between the imine carbon atom and positions 3 or 4 of the
piperidine ring, respectively (Figure 8). In addition, an ap-
propriate substitution on the piperidine C3 position might
also be used to obtain the Eburnane framework after re-
arrangement to an indoloquinolizidine.
2.2. Synthesis of Strychnos-type compounds via protected
2-indolyl-4-piperidones
To synthesize Strychnos-type compounds, we first prepared
2-(3-indolyl)piperidines 8a and 8b following our methodolo-
gy (Figure 9) [6]. Piperidines 8a and 8b bear an acetate
chain on the 4-position, cis with respect to the indole sub-
stituent, and are epimeric on C-5. Treatment of the mixture of
8a and 8b with an excess of KtBuO followed by addition of
BF3.Et2O to the reaction medium provided a mixture of com-
pounds 10 and 11 (Figure 9). Indoloquinolizidine 11 was al-
ready known to be a precursor of dihydrocorynantheol [7],
and compound 10 was identified as tetrahydroakuam-
micine. We had thus achieved a formal synthesis of dihydro-
Figure 9
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corynantheol, and opened a new synthetic route to the pen-
tacyclic Strychnos structure [8,9].
2.3. Attempts to synthesize the Eburnane and
Aspidosperma alkaloids
According to our reasoning (Figure 8), it should be possible
to synthesize the Eburnane-type structure 12 by closing the
C16-N1 bond after rearrangement of a spiroindolizidine 13 to
the corresponding quinolizidine (Figure 10). Com-
pound 13 would be obtained from 2-indolylpiperidine
14 by treatment with KtBuO.
However, when we treated piperidine 14 with KtBuO
under the conditions normally used to obtain spiroin-
dolenine 13, and then induced rearrangement to the in-
doloquinolizidine 15 using BF3·Et2O, the only products
obtained were tryptophylpiperidines 16 (Figure 11) [10].
We had already observed that spiroindolenines car-
rying substituents on the piperidine C3 [11] or the in-
dole C2 [12] positions evolve naturally to trypto-
phylpiperidines type 17 through opening of the pyrrole
ring by anchimeric assistance of the nitrogen atom. It
appeared that the ring opening was quicker than the
rearrangement because of the steric interaction. In the
absence of a nucleophile or oxidizing agent [5b], the
resulting iminium salt (type 17) would usually evolve to
the corresponding enamine. However, in the present case,
the lack of a hydrogen atom on C3 prevents the tautomeric
equilibrium of 17, and a Wagner-Meerwein rearrangement of
the ethyl chain takes place, followed by elimination to give
the stable unsaturated ester 16.
In any case, the high instability of the intermediate spiroin-
dolenine 13 rendered our strategy unsuitable for obtaining
either Eburnane or Aspidosperma alkaloids.
Figure 12
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3. Unsaturated
valerolactams and 
2-cyanopiperidines (II)
In the light of our previous re-
sults, we planned to obtain both
the Aspidosperma and the
Strychnos frameworks by closing
the pyrrole C ring (Figure 8) on a
suitable ABED tetracyclic sys-
tem, a strategy that had already
been reported [13]. The bridged
tetracyclic framework of the
Strychnos alkaloids constitutes
the structure of dasycarpidone
alkaloids. In the case of Aspi-
dosperma, the preparation of a
pyridocarbazole was necessary.
We devised a single ap-
proach for synthesis of both
tetracyclic ring systems, with the
key step being the closure of the
bond between the indole nucle-
us and the piperidine C2-posi-
tion (Figure 12). We chose 2-
cyanopiperidines 19 and 22 as
latent iminium salts, with lactams
20 and 23, whose partial reduc-
tion would also provide the de-
sired iminium salts, as alterna-
tives. The nucleophile indole
synthon in both cases would be
2-(1,3-dithian-2-yl)indole 21.
3.1. Synthesis of Aspidosperma-type compounds
We first carried out the condensation of 3-chloromethyl-
piperideine 19 with the dianion of indolyldithiane 21, to
obtain compound 24. Sequential Ni-Raney reduction
and cyclization with rhodium chloride triphenylphos-
phine complex [14] then led to the target compound 26
(Figure 13) [15]. However, this method did not allow cy-
clization in the presence of the sulfur atoms, and thus
limited considerably the possibilities of functionalizing the
system.
To circumvent this problem, we prepared the pyridocar-
bazole tetracycles 28 by conjugate addition of the dianion of
dithiane 21 on 3-methylenelactams 20a, followed by treat-
ment of the adduct with DIBAH (Figure 14). The reduction
takes place with spontaneous cyclization of the iminium salt
to give the desired pyridocarbazoles 28 (C/D ring junction
cis and trans) and their regioisomer, the naphthyridoindole
29 [16]. Naphthyridoindole 29 was isomerised to compound
28 in 50% aqueous AcOH. 
Subsequently, we introduced an ethyl chain on C3 by a
tandem conjugate addition-alkylation reaction, using lactam
20b as the starting material. In this case, only the C/D cis
pyridocarbazole was obtained, and closure of the pyrroli-
dine ring followed by reduction of the dithiane ring yielded
the alkaloid aspidospermidine (Figure 15) [16].
3.2. Synthesis of dasycarpidone-type alkaloids
Previous synthesis of the dasycarpidone ring system (Fig.
16) had been based on closure of ring C (a, b) or ring D (c),
or by indolization (d).
To obtain the dasycarpidone ring system, we generated
the iminium salt 35 by treating the 2-cyanopiperidine 22a
with AgBF4 (Figure 17). The dianion of indolyldithiane 21 was
generated in an adjacent reaction, and then added via can-
nula to the dihydropyridinium salt. The major adducts de-
rived from this reaction were 37, derived from condensation
on the indole 3-position. The minor products were compound
39a, identified as the direct precursor of 20-epidasycarpi-
Figure 17
Figure 1
Figure 16
Piperidones: from alkaloids to pseudopeptides 69
done, and 2-cyanopiperidine 38, which yielded the dasy-
carpidone precursor 39b upon cyclization with AcOH [17].
Thus, the target compounds were obtained, but in very low
yield owing to the poor regioselectivity of the condensation. 
To avoid the regioselectivity problem, we performed the
conjugate addition of the indolyldithiane anion on the ,-un-
saturated lactam 23c or 23d (Figure 18).
Lactams 23c and 23d were prepared
from -valerolactam by N-alkylation,
phenylselenylation on the 3-position and
subsequent oxidation/elimination of the
selenide by treatment with MCPBA. 
The Michael-type addition of the dian-
ion of indolyldithiane 21 on lactam
23c or 23d in THF yielded the ex-
pected adduct 40 as the only prod-
uct (Figure 19). Partial reduction of
lactam 39 was achieved with LiAlH4
in the presence of cyanide anions,
and led to a mixture of piperidine
41, 2-cyanopiperidine 42 and
methanodiazocinoindole 43. Treat-
ment of compounds 42 and 43 with
50% aqueous AcOH transformed
both to the target dasycarpidone-
type tetracycle 44, in high yield.
We envisioned the isomerization
of methanodiazocinoindole 44 oc-
curing as depicted in Figure 20. In
the acid medium the indole 3-posi-
tion is rapidly protonated leading to
formation of the iminium salt 45.
This, through an imine-enamine tau-
tomerism, then cyclises to give the
regioisomeric dasycarpidone me-
thanoazocinoindole ring system.
We subsequently applied this strategy to the diastereose-
lective synthesis of compounds 47 and 48 (Figure 21), using
the chiral lactam 23e as the electrophile [18]. Lactam 23e,
an (R)-(-)-phenylglycinol derivative, was prepared by oxida-
tion of the corresponding saturated lactam [19]. In this
study, the reduction/cyclisation step was improved by the
use of Red-Al®.
We also applied the methodology to the preparation of
compounds 49 (R = Bn, Me), which were converted to the
corresponding acylindole derivatives 50 and the alkaloid 20-
epidasycarpidone, respectively (Figure 22) [20]. In this
case, the unsaturated valerolactams required 23a and 23b
were obtained by DMD oxidation [21] of the corresponding
2-cyano-3-ethyl-3-piperidein-2-ones 22a and 22b.
3.3. Lactam Pseudopeptides: 3-Amino-4-indolyl-2-
piperidone
The use of unsaturated lactams as Michael acceptors had
proved to be a very efficient synthetic procedure. Moreover,
the conjugate addition of aromatic moieties on 3-piperi-
dein-2-ones indicated a possible entry to 4-aryl-2-piperido-
ne synthons, which, together with our experience in the pre-
paration of 3-aminopiperidine derivatives (see Section 4.1),
led us to focus on the preparation of 3-amino-4-indolylpiperi-
din-2-ones type 54 (Figure 23). Compound 54 was designed
as a conformationally constrained analogue of the dipeptide
Trp-Gly (see Section 6), in which the restriction caused by
Figure 19
Figure 20
Figure 21
Figure 22
Figure 23
70 Pilar Forns, Mario Rubiralta and Anna Díez
cyclization between the -carbon of tryptophan and the ni-
trogen atom of glycine constrains the conformational space
occupied by the indole nucleus of Trp. Furthermore, the dy-
namics of the ring imposes the orientation of its substituents,
and as a result, the  torsion angles of both Trp and Gly are
also restricted. The synthesis of compound 54 was envisa-
ged as occuring through a conjugate
addition of indole on lactam 52 follo-
wed by a Curtius rearrangement to in-
troduce the amino group on C3 (Figure
23) [22].
The synthesis of the unsaturated lac-
tam 52 was started from N-Boc--
valerolactam 55 (Figure 24). Acylation
on C3 with benzylchloroformate, fol-
lowed by phenylselenylation on the same position,
yielded lactam 56. The successive deprotection of
the nitrogen atom and introduction of the acetate
chain was done at this stage, since the unsaturated
secondary lactam 57 was highly unstable. Alkylation
of 58 in basic medium, and addition of MCPBA to
the reaction, gave the desired lactam in 60% yield. 
The conjugate addition of indole was performed
in the presence of Montmorillonite® [23], yielding a
mixture of the racemics cis and trans 59 (Figure
25). Compounds 59a and 59b were separated by
analytical reverse phase HPLC. However, in the
presence of SiO2, epimerization of C3 resulted in
partial interconversion of 59a and 59b.
When the mixture of lactams 59 was submitted
to the Curtius rearrangement using DPPA and Et3N
in the presence of dibutyltin dilaureate, carbamate
60 (Cbz/OtBu) was obtained. Only the trans-isomer
was observed. In order to adapt our {Trp-Gly} pseu-
dodipeptide for solid phase peptide synthesis, we
also prepared the Fmoc/OtBu derivative 61 by stan-
dard methods. 
4. 3-amino-2-arylpiperidin-4-ones
4.1. 3-Aminopiperidines as Substance P inhibitors
In the early 1990’s we became interested in prepa-
ring 3-aminopiperidine derivatives, since
many compounds that contained this
substructure showed medically relevant
activities. For instance, the marine pseu-
dodistomines (Figure 27) showed antitu-
mor properties, cyclo-arginine is a com-
ponent of antithrombotic agents, and other derivatives were
active at different levels of the nervous system. The introduc-
tion of a 3-amino moiety on our piperidine synthons therefore
appeared likely to enhance the pharmacological interest of
our synthetic chemistry.
Particularly interesting was the peptide mimetic CP-9,994
[24], which inhibits in vitro the undecapeptide known as
Substance P (SP). SP is found in the central and the periph-
eral nervous system, and was known to participate in
processes of inflammation and pain [25]. The discovery of
CP-9,994 stimulated great scientific excitement at the time,
since the regulation of SP levels appeared to be a possible
key to the treatment of inflammatory diseases. We designed
a structural analogue of CP-9,994, compound 62, as a syn-
Figure 24
Figure 27
Figure 25
Figure 26
Figure 28
Piperidones: from alkaloids to pseudopeptides 71
thetic target potentially able
to inhibit SP. 
The first problem was to
establish a method for intro-
ducing an amino group on the
3-position. Of the known ami-
nation methods, we chose to
try the Neber rearrangement,
an old reaction that allows the
introduction of an amino
group on the -position of ke-
tones [26]. On the other hand
this reaction had never been
shown to work on nitrogenat-
ed substrates. We first verified
that the method works on N-
benzylpiperidin-4-one, by for-
mation of the oxime, tosyla-
tion, and treatment of the
tosyloxime with NaEtO in
EtOH (Figure 28). When the
method was applied to substrates arylated on C2, the re-
arrangement yielded both, the 3– and the 5-amino derivatives
66 and 67. We observed that the regioselectivity of the re-
arrangement depended on the stereochemistry of the inter-
mediate tosyloxime. Thus, the amination took place «anti» with
respect to the tosyloxime, which indicated that the intermedi-
ate azirine 69 was formed by a backside attack of the anion on
the nitrogen atom. The subsequent opening of the azirine ring
occured by the action of the EtOH used as solvent, to give ac-
etal 70. In this way we obtained a small collection of 3-amino-2-
arylpiperidin-4-ones. These proved to be inactive as SP in-
hibitors. However, we had demonstrated for the first time the
usefulness of the Neber rearrangement on a piperidone.
4.2. Aza-Eburnane alkaloids
In connecting our studies on the Neber rearrangement to the
indolo[2,3-a]quinolizidine alkaloids (see Section 2), we deci-
ded to prepare 1– and 3-aminoindolo[2,3-a]quinolizidin-2-
ones (Figure 29). These compounds would lead respectively
to the pentacyclic aza-Eburnane and aza-Yohimbe alka-
loids, in which the extra nitrogen atom is located in ring E. Si-
milar aza-Eburnane systems had shown to be able to modify
the induction of tyrosine hydroxylase [27]. We planned two
approaches for the synthesis of aza-Eburnane compounds,
via closure of ring C or of ring E in the last step.
Since the pyridopirimidinoindole tetracyclic system of
compound 71 (Figure 30) was unprecedented in the litera-
ture, we studied its preparation first. Treatment
of 3-amino-2-indolylpiperidine 72 with benzyl
chloroformate yielded only compound 73 in very
low yields, whose structure was inferred from its
analytical data. We concluded that even if the
ABED tetracycle was formed, its functionaliza-
tion provoked a spontaneous elimination in the
reaction conditions, and that the loss of the ma-
Figure 29
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jority of the product could be the result of a subsequent
aromatization.
Closure of ring C on compound 73 to give the aza-Ebur-
nane type compound 74 was unsuccessful, which was ex-
plained by the high rigidity of the substrate and the de-
creased nucleophilicity of the indole C3-position. 
The second approach to the
synthesis of aza-Eburnane sys-
tems was started by the prepa-
ration of 1-aminoindoloquino-
lizidine 75 (Figure 31). This was
done either by closure of ring C
on aminopiperidine 76, or by
amination of indoloquinolizidin-
2-one 77. The pentacyclic sys-
tem was obtained quantitatively
from 75 by formation of the car-
bamate 78 followed by base-induced cy-
clization [28].
5. 3-aminolactams
5.1. Introduction
In the early 1990s we became interested in
the possibility that piperidones might be
used as pseudopeptides and as peptide
mimetics. As drugs, peptides and proteins
tend to suffer from low bioavailability and
rapid degradation. Furthermore, the larger
and more flexible the molecule, the more
likely it is to interact with a wide range of re-
ceptors, with corresponding loss of speci-
ficity. Small molecules with a longer half-life
that bind to a particular receptor may thus
be more active than the native peptides or proteins they
mimic. Another aspect to be taken into account is that the in-
teraction between the receptor and the peptide active site
depends on the conformation of both. Since small molecules
have more limited conformational variability, productive in-
teraction with their receptors is likely to be more frequent
than that of larger peptides.
One of the major structural motifs that characterise recep-
tor recognition sites of peptides is the -turn (Figure 32) [29].
3-Aminolactams were first reported to be able to induce -
turns by Freidinger in 1982 [30]. Since then numerous struc-
tures that mimic or induce -turns have been developed. In
1992 Siegl reported a synthesis of 4-phenyl lactam 80, as a
constrained analogue of phenylalanine [31]. This, together
with the relevance that peptide mimetics were acquiring in
the pharmacological field, focused our attention on the syn-
thesis of diversely functionalized 3-aminopiperidin-2-ones.
Not only do our structures present interesting biological ac-
tivities per se as enzyme inhibitors, but they can also be
used as dipeptide surrogates to study structure-activity rela-
tionships of known active peptides. 
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5.2. Simple 3-aminolactams as conformationally restricted
surrogates of alanine
We envisaged the synthesis of diversely N1-substituted 3-
aminovalerolactams, since we regarded these as one of the
simplest structures that can be considered as constrained
derivatives of alanine. The Ala-Gly surrogate 84, described as
an ACE inhibitor [32], has been prepared by two methods: N-
alkylation of Cbz-cyclo-ornithine with benzyl bromoacetate
[33], and lactamisation of N-substituted ornithine (Figure 33)
[32,34]. Since our intention was to be able to introduce any
substituent on the lactam nitrogen atom, we explored the pos-
sibility of closing the C6-N1 bond by intramolecular nucle-
ophilic substitution of an -bromoamide [35].
Coupling of bromoacid 81 [36] with glycine-OBn using
DCC/HOBt yielded the desired bromoamide 82, whose treat-
ment with NaH led to the expected valerolactam 83. Reduc-
tion of the azido group by hydrogenation in the
presence of Lindlar catalyst yielded the target
Ala-Gly surrogate 84.
We then applied the cyclisation method to the
preparation of {Ala-Leu} 88. Coupling of bro-
movaleric acid 81 to Leu-OBn using DCC/HOBt
gave amide 85 in 38% yield, and treatment of 85
with NaH furnished the expected lactam 87 (Fig-
ure 35). However, this series of reactions had
two drawbacks. Compound 86, resulting from
nucleophilic attack of HOBt on the bromide, was
identified as a by-product of the coupling, which
accounted for the mediocre yields obtained,
and, most importantly, the NaH cyclisation oc-
cured with racemisation at C3. 
In order to avoid the SN reaction competing
with the coupling, we performed the condensa-
tion of the bromoacid with Leu-OBn in the pres-
ence of Et3N. In this manner, the intermediate
lactone 89 was generated by cyclisation of the
carboxylate, which then reacted with Leu-OBn
to give hydroxyamide 90 quantitatively. Treat-
ment of 90 with DEAD/PPh3 led to the desired
azidolactam 91 without racemisation.
In parallel with the previous study, we as-
sayed the solid phase synthesis of 3-amino-
valerolactams by formation of the N1-C2 bond
through intramolecular coupling of a secondary
amine and a carboxyl group (Figure 36). As not-
ed earlier, this strategy had been reported to cy-
clise N-substituted ornithine [33]. However, we
needed to be able to introduce an asymmetric
centre  with respect to the N nitrogen atom.
For this purpose, we decided to use a suitable
amine as a nucleophile on the mesylate of 5-hy-
droxynorvaline.
We first established a new method for the
preparation of (S)-5-hydroxynorvaline (Figure 37)
[37]. This involved protection of the aminocar-
boxyl extremity of glutamic acid using BEt3, and
reduction of the -carboxylate with BH3.
(S)-5-Hydroxynorvaline was anchored to a
solid support (PS(BHA)-IRAA-HMPP resin) by
carbonate activation of the resin. The hydroxyl
group was replaced by 4-aminobenzylamine via
Figure 39
Figure 40
Figure 42
Figure 41
74 Pilar Forns, Mario Rubiralta and Anna Díez
mesylation, to give the open chain aminoacid 96 in high
yields (Figure 38). Subsequent cyclisation was effected by
intramolecular DIPCDI/HOBt coupling of the secondary
amine. The final cleavage from the resin was carried out by a
20% TFA/CH2Cl2 treatment to give lactam 98 [38].
We are currently studying the generality and scope of
these two methods by the preparation of small libraries of 3-
aminovalerolactams, both in solution and on solid support.
6. Glutarimides
A somewhat more ambitious goal was the preparation of 3-
aminovalerolactams substituted on positions C4, C5 and C6.
In particular we wished to prepare 4-in-
dolylvalerolactam 99 and 5-methylthio-
lactam 100, constrained analogues of
Trp and Met, respectively (Figure 39). 
Various constrained derivatives of
tryptophan had already been reported.
These can be classified as shown in
Figure 40. A first group of derivatives
contain the -position of Trp linked to
the indole nucleus 4-position, via a car-
bon bridge that renders C quaternary.
A variation of this method consists of
linking the amino group to the indole 4-
position, by either a carbon chain or
another aminoacid (here Val) to yield rings of 7,
8, or 9 members. A third class of derivative in-
cludes the - and -carbons of Trp in a 3-
aminolactone ring, whose synthesis was
achieved starting from an appropriate carbohy-
drate. Other derivatives show the cyclisation
between the amino group and the indole 2-posi-
tion, either directly to form a fisostigmine-type
compound, or through a carbon atom to yield a
-carboline, via a Bishler-Napieralsky conden-
sation of Trp with the aldehyde of Ser followed
by coupling.
Our 3-aminovalerolactam was therefore a
new derivative of Trp, in which the -position
was tethered to the amino group of the follow-
ing amino acid residue (aa2) by a 2-carbon
bridge. In this fashion, the , (Trp), and
	1(Trp) dihedral angles are constrained by the
six-membered ring, with a concurrent effect on
the (Trp), 	2(Trp), and (aa2) dihedral angles
which are obliged to move cooperatively with
the ring. 
Because of our experience with synthesis of
(R)-phenylgycinol-derived lactams in the dasy-
carpidone alkaloids (see Section 3.2), we de-
cided to establish the synthetic strategy by
preparing 3-amino-4-indolylpiperidin-2-one
101, by reduction of a 4-indolylglutarimide (Fig-
ure 41). We considered two different approach-
es: performing the amination as the final step of the synthe-
sis, or introducing the C3 amino group on the starting
substrates. In both cases the imides would be prepared by
reaction of an appropriate anhydride with (R)-phenylglyci-
nol, a strategy that should allow us to diversify the synthesis
by the use of any primary amine.
6.1. Tryptophan-phenylglycinol derivatives
We first obtained the 4-indolylglutaric anhydride 103 from N-
benzylindole-3-carbaldehyde (106). A Wadsworth-Emmons
condensation with ethyl diethylphosphoroacetate, followed
by a malonic synthesis, yielded 4-indolylglutaric acid 109
(Figure 42), which was then cyclized by mesylation and
base treatment. The condensation of anhydride 103 with (R)-
Figure 43
Figure 44
Figure 45
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phenylglycinol and the subsequent addition of AcCl led to
the desired prochiral glutarimide 102.
Reduction of imide 102 was performed by treatment with
NaBH4 in acid medium, and yielded a mixture of the 6-hy-
droxylactams 110 and 111, together with a small proportion
of hydroxyamide 112 (Figure 43). Formation of hydrox-
yamide results from the reduction of the intermediate open-
chained aldehyde [39]. Reduction of position C6 by
Et3SiH/TFA, followed by chromathography on SiO2 and
saponification of the acetyl group led to the desired lactam
113. Lactam 113 was also obtained by cyclisation of the hy-
droxyamide 112 through mesylation and subsequent treat-
ment with NaH. 
The assays of direct amination on C3 using trisylazide did
not yield the expected 3-azidolactam 117, but rather the dia-
zoderivative 116 which we were unable to reduce to the
amine (Figure 44). We then prepared 3-bromolactam 114,
but unfortunately the acidity of the proton on C4 was suffi-
cient to make the bromolactam undergo a dehydrohalo-
genation upon treatment with benzylamine or with
NaN3, resulting in piperideinone 115.
The second approach circumvented this problem
by using a starting substrate bearing the amino
group on the C3 position. Thus, 4-indolylglutaric an-
hydride 122 was prepared from indolyl-3-carbalde-
hyde 106 in a sequence that involved a Henry-type
reaction, followed by a conjugate addition of di-tert-
butyl malonate to yield triester 119 (Figure 45). The
reduction of the nitro group was performed at this
stage, and the amino function was Alloc-protected.
In this fashion, the erythro and threo racemic mix-
tures 120a,b were obtained, and were separated by
column chromatography. The major threo triester
120b was used to prepare the corresponding diacid
121, which was cyclized as in the previous series to
obtain the trans-anhydride 122.
The synthesis of the target lactam 126 from anhy-
dride 122 was carried out by applying the sequence
that we had established previously, i.e. by formation
of the glutarimide (two trans diastereomers), reduc-
tion and cyclisation [40]. However, in this case, the
reduction of imide 123 with NaBH4/HCl led only to the
open chain hydroxyamide 124, whose mesylate 125
was cyclized using DBU as the base (Figure 46). 
The same chemistry was applied using the minor
erythro-triester 120a, to obtain the cis diastereo-
mers.
6.2 Tryptophan-serine derivatives
We next tried to apply the method the synthesis of Trp-Ser
surrogates. Thus, condensation of the threo anhydride 122
(2 diastereomers) with di-tert-butylserine yielded 127, the
glutarimide necessary for our study (Figure 47). 
Since, in our experience, the use of NaBH4/HCl as the re-
ducing agent for glutarimides led to mixtures of the open
chain hydroxyamide and the hydroxylactam in very variable
proportions [41], we tried the reduction of 127 using Li-
BEt3H. Of the two possible products, only hydroxylactam
128 was obtained. The dehydroxylation was effected by
treatment with TFA/Et3SiH to obtain the desired 3-amino 4-in-
dolylpiperidin-2-one 129. The selective cleavage of the Alloc
protecting group was performed with NaBH4 in the presence
of a Pd catalyst to yield the H-{Trp(Bn)-Ser(tBu)}-OtBu
pseudopeptide 130.
However, we were confronted to two major problems: fail-
ure to separate the diastereomeric anhydrides, glutarim-
ides, or lactams by standard chromatographic methods,
and inability to debenzylate the indole nucleus (Figure 48).
The pseudopeptides obtained were therefore
neither pure nor easily and selectively depro-
tected, and were hence unsuitable for further
synthetic purposes. 
However, we later succeeded in preparing
Trp constrained derivatives by using conju-
gate addition of indole on an appropriate un-
saturated lactam, as described in Section 3.3. 
Figure 46
Figure 47
Figure 48
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7. Enamides
As outlined in the introduction to Section 6 (Figure 39), we
also aimed to synthesize 3-amino-5-methylthiovalerolac-
tams 100, as constrained surrogates of Met. In conjunction
with the studies on glutarimides, we envisaged the possibi-
lity of using 6-hydroxylactams to yield cyclic enamides by
dehydration, and of using the double bond to functionalize
position C5 (Figure 49). Since there was little information on
the reactivity of enamides, we decided to prepare the met-
hionine-phenylglycinol derivative 138, using the intermedia-
te enamide 133 as a model. 
The enamides appeared to be very attractive synthons;
not only can they be regarded as constrained derivatives of
Ala, their potential reactivity should allow functionalization on
positions C4, C5, and C6 of the valerolactam ring.
7.1. Methionine-phenylglycinol [42]
Several ways to constrain the mobility of the methionine side-
chain had been reported in the literature (Figure 51). When a
thiirane ring [43] or of a double bond [44] is introduced the
-position remains tertiary. Otherwise, the -position is in-
volved in the formation of a bridged bicycle [45] or of a cy-
clopropane ring [46], yielding quaternary derivatives. Final-
ly, a compound isolated from human urine, contains the
structure of methionine as part of a seven-membered ring
[47]. Our 3-amino-5-methylthiolactam maintains both the
methylsulfide function and the tertiary -position, and
binds the side chain to the nitrogen atom of the following
amino acid with an ethylene bridge. As in the case of the
Trp derivatives, the level of constraint is high, affecting
most dihedral angles of the amino acid.
To prepare compounds 134, glutarimide 131 was par-
tially reduced with Superhydride®, and the resulting hy-
droxylactams 132 were dehydrated using TFA to produce
the expected enamide 133 in 60% yield (Figure 52). The
methylthiolation of C5 was achieved by addition of MeSH
to the double bond in the presence of AIBN, whereas the
enamide did not react with electrophilic reagents such as
MeS-S(O)Me. This demonstrated that the electron with-
drawing effect of the carbonyl group (C2) was sufficiently
strong to make the double bond of the enamide behave
as an isolated alkene rather than as an enamine. As ex-
pected, the radical addition yielded an equimolar mixture
of the antiMarkovnikov regioisomers, 134a and 134b,
which were separated by column chromatography.
Amination of the 3-position was carried out by bromina-
tion and substitution (Figure 53). Thus, treatment of the
methylthiolactam (R,5S)-135 with sec-BuLi and bromine
led to a 5:1 diastereomeric mixture of 3-bromolactams
136a and 136b. The 3,5-cis isomer spontaneously epimer-
ized to give the thermodynamically more stable 3,5-trans
isomer, both in solution and in the presence of SiO2.
Substitution of the bromine atom by NaN3 yielded com-
pound 137 as a single isomer, which was reduced to ob-
tain the (aR,3R,5S) {Met-phenylglycinol} 138a. When the
bulkier potassium phthalimide was used as the nucle-
ophile, we obtained a 5:1 C3 epimeric mixture of 3-phthalim-
idolactams 139, which were separated by chromatography.
Deprotection of isomer 139b yielded the (aR,3S,5S) {Met-
phenylglycinol} 138b.
7.2. Methionine-serine [48]
Since amination on C3 using a strong base is incompatible
with the acidity of the -proton of amino acids, it appeared
advisable to use glutamic anhydride as the starting substrate
for the preparation of dipeptide analogues. The key enam-
ides could then be obtained either by partial reduction of the
corresponding imide, or by closure of the N1-C6 bond from a
formylamide (Figure 54). Both general approaches should
Figure 51
Figure 49
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enable us to prepare small series of pseudodipeptides, first
by diversifying the second amino acid (aa2), and eventually,
by diversifying the functionalisation of the lactam ring.
Condensation of glutamic anhydride 140 with di-tert-butyl
serine led to the corresponding imide in 60% yield (Figure
55). The reduction of imide 141 with Superhydride(r) gave the
expected 6-hydroxylactam 142 in 50% yield. When we tried
the reaction using NaBH4/HCl as the reducing agent, only
the open chain hydroxyamide 143 was obtained, and DIBAH
led to a mixture of 142 and 143, but in vari-
able proportions. Although we tried to de-
hydrate hydroxylactam 142, the starting
substrate remained unaltered under all
conditions used (TFA; p-TsOH; 1.
MsCl/TEA, 2. DBU; POCl3, pyridine;
NH4Br). These unexpected results made
us turn our attention to the second ap-
proach.
The alternative was to prepare an open
chain formylamide 148, whose cyclisation
would yield the target enamide 149 (Fig-
ure 56). We decided to generate the alde-
hyde function by reduction of the corre-
sponding thioester. Thus, treatment of
glutamic anhydride 145 with phenylthiol in
the presence of dicyclohexylamine yield-
ed thioester 146 quantitatively, and this
was condensed with di-tert-butyl serine
under standard conditions to obtain
amide 147. The reduction of compound
147 using Et3SiH in the presence of Pd/C
in CH3CN:CH2Cl2 led to the key aldehyde
148, and treatment of 148 with acid gener-
ated the desired enamide 149 in 45%
yield (2 steps) after column chromatogra-
phy on SiO2.
Once the enamide had been obtained,
methylhiolation with MeSH in the pres-
ence of AIBN in THF gave the target {Met-
Ser} constrained derivative 150.
In order to test the generality of this
method for synthesizing {Met-aa2} deriva-
tives, we repeated the synthetic se-
quence using other amino acids. Since one of our aims is to
determine whether our pseudodipeptides can induce partic-
ular conformations once inserted in longer peptide chains,
we chose to prepare {Met-Val} and {Met-Leu}. The Ra-
machandran plots of valine and leucine show that they show
high potential for -sheet and -helix conformation, respec-
tively.
Condensation of thioester 146 with Val and Leu, followed
by the reduction of the thioester function and final acid cycli-
Figure 54
Figure 55
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sation of the aldehydes, yielded enamides 153 and 154 (Fig-
ure 57). In each case the separation of the two diastere-
omers was done by serial chromatography. Methylthiolation
was performed on the pure diasteromers 153a and 154a to
give a 3:1 proportion of the methionine-derived pseu-
dopeptides. The major isomers were always the 3,5-trans
forms (a), in which the methylsulfide group was axially dis-
posed. We attributed the unequal proportion to a steric ef-
fect of the bulky C3 phthalimido substituent. 
7.3. Application to the solid phase synthesis of enamides
[49]
Our next aim was to synthesize enamides on solid phase. In
this fashion we would be able to diversify their N1-sub-
stituent, and subsequently carry out parallel functionalisa-
tions of the ring. This exponential diversification would result
in small libraries of lactam
pseudopeptides. For this purpose,
the above sequence (Figure 57)
had to be modified to make it com-
patible with the resin. The first step
was to test the feasibility of the pro-
cedure using a carbamate N-pro-
tection such as Cbz. Since there
was no regioselectivity in the ring
opening of anhydride 157 (Figure
58) we could not apply the same
strategy as that used in the phthal-
imido series (Figure 56). Hence,
Cbz-Glu was transformed to the
amidoacid 161 after condensation of the oxazolidinone 160
[50] with Leu-OMe. The reduction of the acid group in 161
via an acid chloride yielded the pyrrolidone 162, as a result
of cyclisation on the carbamate nitrogen atom (Figure 58).
In order to avoid the formation of the pyrrolidone ring, the
reduction of the acid group was carried out on compounds
160 [51] via a thioester intermediate 163. The aldehyde was
protected as a dimethylacetal, and compound 165 was cou-
pled with Leu-OMe to yield 167. Various cyclisation condi-
tions were assayed, but only with p-TsOH was the desired
enamide 168 obtained (6%), together with a more polar
compound identified as 5-hydroxyproline 169 (Figure 59). 
At present we are optimising this cyclisation to enable us
to start the sequence on solid phase using a Tentagel(r)-
IRAA-HMPP-O-CO resin.
8. Oxazolopiperidines [52]
8.1. Introduction
As explained in Section 5, we are interested
in obtaining pseudopeptides that can in-
duce a particular conformation once insert-
ed in a longer peptide chain. More specifi-
cally, one of the conformations that we seek
is the -turn, since it is known that bicyclic
compounds can be good -turn mimetics
[53]. For instance, compound 170 (Figure
60) [54] has been extensively studied in the
context of building active peptide ana-
logues.[55-61]. Despite the role played by
the -turn position itself in the interaction
with the receptor and the fact that 170 in-
duces a II’ turn conformation in collabora-
tion with the adjacent residues, this -turn
dipeptide seems not to be very useful for im-
proving the activity of small peptides, in
which the -turn position itself plays some
role in the interaction with the receptor site
[62]. Interestingly, recent molecular model-
ing calculations on the tetrapeptide Ac-Ala-
{170a}-Ala-NHMe indicate that the geometry
of a turn induced by thiazolopiperidone 170Figure 58
Figure 57
Figure 56
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differs significantly from that of an ideal -turn
[63]. In addition, the incorporation of either
epimer 170a or 170b in a bioactive peptide
has been shown to provoke distinct changes in
its bioactivity [60a].
We thought that the isosteric substitution of
the sulfur in the 7-position by an oxygen atom
might improve the binding properties of the -
turn dipeptide, since oxygen could act as a
better hydrogen bond acceptor on the «exter-
nal part» of the turn. With the aim of establish-
ing the possible utility of oxazolopiperidones
171 as -turn mimetics, we have prepared
these bicyclic lactams and their derivatives
173 (Figure 61). The conformational analysis
of 173, both by NMR and by molecular modeling calcula-
tions, indicate that oxazolopiperidone 173a mimics a II’ turn
and that 173b adopts a -turn conformation that does not
correspond to the classified types [1b-e,2].
8.2. Synthesis and structural studies
The preparation of oxazolopiperidones 172 was achieved by
condensation of aldehyde 164 [50] with methyl serine hy-
drochloride (Figure 61). When the reaction was conducted
at room temperature, isomer (3S,6S,9S)-172a was obtained
pure, whilst the condensation in refluxing toluene yielded a
1:5 mixture of 172a and its C6 epimer 172b. The absolute
configuration of each isomer was determined by NOESY ex-
periments. Amidation of compounds 172 with MeNH2 led to
compounds 173, which fulfil all the requirements necessary
for studying the conformational tendencies of the bicyclic
oxazolopiperidone system. 
The conformation of 173a and 173b was studied by com-
bining molecular modeling calculations and NMR techniques.
NMR experiments were used to determine the existence of an
intramolecular hydrogen bond between the oxygen atom of
the Cbz carbonyl group and the amide
NH proton, which is the sine qua non for
pseudodipeptide occupation of the
(i+1) and (i+2) positions of a standard
-turn. Molecular modeling calcula-
tions were used to find the most prob-
able conformations of each isomer
(6H- and 6H-), and to determine,
according to the dihedral angles in-
volved, which kind of -turn they corre-
spond to. 
Similar results were obtained for
both isomers 173a and 173b by NMR
experiments (Figure 62). Thus, follow-
ing the classification of Scolastico and
co-workers [64], chemical shifts in
CDCl3, temperature coefficients in
CDCl3, and the results of competitive
solvent addition (DMSO) experiments
Figure 59
Figure 60
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Figure 62a. Solvent dependence of the 1H-NMR chemical shifts for compound 173a.
Figure 62b. 1H-NMR Chemical shift of the NH protons of pseudodipeptide 173a at different pro-
portions of d6-DMSO in CDCl3 (25ºC). Figure 63
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showed that the NHi carbamate proton was not hydrogen-
bonded, and that the NHi+3 amide proton was intramolecular-
ly hydrogen-bonded, though weakly. Therefore
both isomers showed reasonable potential for
action as -turn mimetics.
Molecular mechanics/dynamics (MM/MD)
calculations were performed in continuum, in
DMSO, and in H2O. These demonstrate that
173a is an excellent II’ turn mimetic, whereas
173b is more flexible and adopts either unusual
-turns or L-shaped conformations. 
The bicyclic system (3S,6S,9S)-171a is there-
fore a new dipeptide scaffold for the synthesis of
II’ turn mimetics, which might find application in
bioactive peptide-based rational drug design.
9. Hydroxylactams
9.1. Introduction
The last synthon that we present in this review is
the polyhydroxylated piperidin-2-one 174 (Fig-
ure 63). Since polyhydroxylated lactams have
been reported as having interesting biological
activities, such as inhibition of glycosidase activ-
ity [65], cancer cell metastasis [66], and inflam-
mation [67], we considered the possibility of
synthesising a small collection of 3,4,5-trihy-
droxypiperidin-2-ones 174, whose activities
might be modulated by side chain functionalisa-
tion of the amino acid moiety. In addition, trans-
formation of the hydroxyl groups of this synthon
offered a wide range of synthetic possibilities.
Thus, our first aim was to employ the polyhydrox-
ylated synthon in the preparation of 3-amino-
valerolactam 189, a constrained surrogate of the
Ser-Leu dipeptide.
9.2. Synthesis of 3,4,5-trihydroxyvalerolactam
174
The synthesis of compound 174 was directly in-
spired by the lactamisation reaction of aminolac-
tones derived from carbohydrates (Figure 64).
This procedure produces a valerolactam ring with three
stereocentres of predefined configuration. Thus, ribonolac-
tone, protected [68] or not [69], can be transformed to its 5-
azido derivative, whose hydrogenation yields N-unsusbtitut-
ed valerolactams by spontaneous cyclisation of the primary
amine.
In contrast, our synthesis demanded the cyclisation of an
intermediate 5-aminolactone 176 which presented a sec-
ondary amino group, since we wanted to introduce a stereo-
centre adjacent to the N1-position (Figure 65) [70]. Hydroly-
sis of the acetal would lead to the target synthon 174.
Quantitative protection of commercial ribonolactone was
carried out by transacetalisation using acetone dimethyl ac-
etal (Figure 66). To introduce the suitable amino moiety, C5
was brominated using NBS-PPh3 in CH2Cl2, and the result-
ing bromine 179 was treated with Leu-OtBu in the presence
Figure 64
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of Et3N. However, the product ob-
tained was identified as the amide
181, resulting from opening of the
lactone ring, instead of the expect-
ed substitution product 176 [71].
When iodide was assayed as the
leaving group the same result was
obtained. Treatment of amides 181
and 182 with K2CO3 led quantita-
tively to the corresponding
epoxyde 183, which was trans-
formed to the desired lactam 175
on NaH treatment, but in very low
yields.
As an alternative, we prepared triflate 184, whose
reaction with Leu-OtBu yielded the aminolactone 176,
which led to the protected lactam 175 in 90% yield
upon treatment with NaAcO (Figure 67). Hydrolysis of
the acetal furnished the target trihydroxyvalerolactam
174.
9.3. Serine-Leucine constrained analogues
Once the synthesis of compound 174 had been established,
we could proceed to the synthesis of pseudodipeptide 189
as a conformationally restricted Ser-Leu surrogate (Figure
68) [70]. The free alcohol of compound 175 was protected
as a benzyl ether, and the acetal was hydrolysed to give
compound 186. The C3 was aminated by reaction of the sul-
phite 187 with NaN3 in the presence of HMPA [72]. The sul-
phite 187 was obtained as a mixture of the 2 epimers on the
sulfur atom, which could be
separated by chromatography
and fully characterized. The
subsequent attack by NaN3 on
each isomer led only to the 3S
isomer of compound 188.
Subsequent reduction of the
azide group led to the target
{Ser-Leu} pseudopeptide 189.
Compound 189 was suitably
N-protected and C-deprotect-
ed to yield the Fmoc/OH derivative 190,
appropriate for further peptide synthe-
sis on solid phase. 
We intend now to introduce com-
pound 190 in a small cyclic peptide in
order to evaluate its possible applica-
tion as a -turn mimetic. 
9.4. Solid phase synthesis of
hydroxylactams
Once we had established the synthesis
of hydroxylated lactams in solution, we
examined modified versions of it applic-
able to solid phase synthesis, which
would allow the preparation of a small li-
brary of derivatives with various sub-
stituents on the N1 position. Our strategy consisted of anchor-
ing the terminal carboxyl of the aminoacid moiety to a Tent-
agel(r) resin [73], performing the condensation with D-ribono-
lactone 177, and lactamisation (Figure 69). Since
lactamisation is accomplished using NaOAc/MeOH, the
cleavage of the molecule from the resin would be concomi-
tant with the cyclisation [74], and no linker would be neces-
sary [75].
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First, we explored the possibility of aminating ribonolac-
tone 177 using a Mitsunobu reaction, which is mild and suit-
able for solid phase synthesis [76]. This was satisfactorily
achieved by N-alkylation of the sulfonamide derived from
Leu (194) with 177 in the presence of DEAD and PPh3, fol-
lowed by cleavage of the arylsulfone group of compound
195 with PhSH (Figure 70) [77]. Treatment of the resulting
secondary amine 196 with NaOAc/MeOH yielded the ex-
pected lactam 197a.
For the solid phase synthesis we followed Liskamp’s
method [74] since the TentaGel(r) resin conveniently swells
in MeOH, a necessary condition for efficient lactamisation/
cleavage. Parallel anchoring of the Fmoc protected ami-
noacids to the Tentagel(r) resin via a Mitsunobu-type reac-
tion [78] yielded compounds 199a-c which, after capping
with Ac2O, were deprotected to obtain amines 200a-c (Fig-
ure 72). Standard sulfonation of the amines gave the de-
sired compounds 193a-c [79] which were N-alkylated by
treatment with ribonolactone 177 in the presence of DEAD
and PPh3 to obtain the corresponding tertiary sulfonamides
201a-c (Figure 72). The sulfone group was cleaved using
PhSH, and subsequent treatment of the secondary amines
192a-c with NaOAc/MeOH yielded the expected hydroxy-
lactams 197a-c. After removal of the resin, the MeOH sol-
vent was replaced by CH2Cl2 and the products filtered to
yield 197a-c in pure form. The formation of the primary
amines and the sulfonamides was confirmed by positive
and negative ninhydrine tests, respectively.
Finally, treatment of lactams 197a-c with PPTS in MeOH
yielded the target trihydroxylactams 191a-c (Figure 72).
10. Conclusion 
As every painter has a particular colour that helps him cap-
ture very specific feelings or images, we have used the syn-
thetic scope of piperidine to prepare pharmacologically 
interesting compounds. Thus, by modifying the functionali-
sation of the piperidine ring we have been able to obtain
compounds ranging from alkaloids to pseudopeptides. The
reader will realise that this is a dynamic field: we intend to
continue contributing to its development.
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tidomimetics and as restricted pseudo-
dipeptides to be used as surrogates in
longer peptide chains. The targets are
mostly enzyme inhibitors for diverse
therapeutical applications, such as an-
tiinflammatories, antibiotics, and anti-
cancer agents. 
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